CN
2026 / 01 / 01

Yantai Biopharmaceutical and Health Industry Development Group Announces Relocation to New Premises

Yantai, China — May 15, 2026 — Yantai Biopharmaceutical and Health Industry Development Group Co., Ltd. (hereinafter referred to as "Yantai Biomedical Group") has officially relocated its offices from Building 71, Zhongye Qinhai Yunshu, No. 500 Binhai East Road, Ninghai Subdistrict, Muping District, Yantai City, to Building 27, No. 9 Dongxing Street, Dayao Subdistrict, Muping District, Yantai City, effective May 15, 2026. All business communications, document exchanges, and visitor receptions are now being conducted at the new premises. The former office address is no longer in operation.

The relocation marks a new chapter for the Group as it continues to advance its mission in the biopharmaceutical and health industry. In an official notice, the Group expressed its sincere gratitude to industry colleagues and friends from all sectors for their long-term care and support, and stated its commitment to continuing to work hand in hand with partners to create a better future together.

About Yantai Biopharmaceutical and Health Industry Development Group Co., Ltd.

Yantai Biopharmaceutical and Health Industry Development Group Co., Ltd. is the core operating entity for Yantai's biopharmaceutical industry, deeply engaged in the development of Blue Pharma Valley · Life Island. The Group has built a full-chain industrial ecosystem, bringing together high-quality innovative entities in cell drugs, innovative pharmaceuticals, and radiopharmaceuticals, supported by a comprehensive project incubation and achievement transformation system, laying a solid industrial foundation for the commercialization of pharmaceutical innovations.

New Address:
Building 27, No. 9 Dongxing Street, Dayao Subdistrict, Muping District, Yantai City

Contact Number: 0535-4212099